Pazopanib shows positive results in phase II trials

November 1, 2007

Pazopanib, another anti-angiogenesis drug, has shown positive results in Phase II trials for advanced kidney cancer.

For more information about pazopanib, see:

http://www.medicalnewstoday.com/articles/73025.php

 

 

Back to news listings
comments powered by Disqus